NewKerala.com

India Pharma 2026 Aims to Transform Sector into Innovation Powerhouse

The Indian government has announced the India Pharma 2026 conference, a flagship event designed to accelerate the pharmaceutical industry's transition from volume-based to innovation-led growth. Scheduled for April in New Delhi, the event will bring together policymakers, industry leaders, and researchers under the theme "Discover in India." Discussions will focus on emerging areas like drug discovery and biosimilars, aiming to position India as a global hub for life sciences innovation. The initiative aligns with broader national goals to strengthen healthcare access and global health security.

Key Points: India Pharma 2026: Shift from Volume to Innovation-Led Growth

  • Shift from volume to value-led growth
  • Focus on drug discovery & biosimilars
  • Strengthen global supply chains
  • Showcase India's R&D ecosystem
2 min read

India pharma 2026 to push shift from volume to innovation-led growth

India Pharma 2026 conference aims to transition the pharma sector from volume-based to value and research-led global leadership. Learn about the strategy.

"Discover in India: Leapfrogging Life-Sciences Innovation - Event Theme"

New Delhi, March 30

India's pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry's transition from volume-based growth to value and research-led expansion, the government said on Monday.

The Department of Pharmaceuticals under the Ministry of Chemicals and Fertilisers, in association with the Federation of Indian Chambers of Commerce and Industry (FICCI) and the Indian Pharmaceutical Alliance (IPA), will organise the 9th edition of India Pharma 2026 on April 13-14 at Federation House in the national capital.

The conference will act as a key platform for discussions on how India's pharma industry can move beyond being a volume-driven market to becoming a value- and innovation-led global leader.

It will bring together policymakers, global industry leaders, researchers and innovators to explore new opportunities and strategies.

With the theme "Discover in India: Leapfrogging Life-Sciences Innovation," the event aims to position India as a global hub for cutting-edge research and innovation in pharmaceuticals and life sciences.

The focus will be on improving healthcare access, speeding up innovation, and strengthening global health security.

Experts at the conference will discuss emerging areas such as drug discovery, complex generics and biosimilars.

The event will also highlight India's strong manufacturing base and its fast-growing research and development ecosystem, which are helping the country strengthen its position in the global pharmaceutical value chain.

India Pharma 2026 is a flagship initiative designed to showcase India's pharmaceutical capabilities, encourage innovation, and build stronger global supply chains through collaboration and policy discussions.

FICCI, established in 1927, is one of India's oldest and largest business organisations, representing over 2.5 lakh companies across sectors.

Meanwhile, the Department of Pharmaceuticals continues to support the pharma and medtech sectors through policy measures, infrastructure development and industry-academia partnerships, in line with the vision of Viksit Bharat 2047.

- IANS

Share this article:

Reader Comments

P
Priyanka N
As someone working in a CRO, I see the potential daily. The shift from 'Made in India' to 'Discovered in India' is crucial. But we need stronger IP protection and less regulatory red tape to truly attract global R&D investment. The conference must address these practical hurdles.
A
Aman W
Good initiative. But I hope "improving healthcare access" isn't just a line. Innovation should also mean affordable new medicines for our own population, not just exports. Jai Hind!
S
Sarah B
Working with global pharma, India's manufacturing quality is respected. A focused push into biosimilars and complex generics is a smart, strategic next step. The collaboration between government and industry bodies like FICCI is key to making this happen.
V
Vikram M
Finally! We have the talent pool and the scale. Now we need the ecosystem for high-risk, long-term drug discovery. Hope the policies that come out of this encourage our companies to invest more than 1-2% of revenue in R&D. The theme "Discover in India" is inspiring.
K
Kriti O
My father is a doctor and always says we rely too much on imported drugs for critical care. If this initiative can change that, it will be a huge win for national health security. Best of luck to all the participants! 🙏

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50